Critical role of CD4+ T cells and IFNγ signaling in antibody-mediated resistance to Zika virus infection

Nature Communications

Volumn 9, Issue 1, 2018, Pages

  Lucas, Carolina G O ^a   Kitoko, Jamil Z ^a   Ferreira, Fabricio M ^a   Suzart, Vinicius G ^a   Papa, Michelle P ^a   Coelho, Sharton V A ^a   Cavazzoni, Cecilia B ^a   Paula Neto, Heitor A ^a   Olsen, Priscilla C ^a   Iwasaki, Akiko ^b   Pereira, Renata M ^a   Pimentel Coelho, Pedro M ^a   Vale, Andre M ^a   de Arruda, Luciana B ^a   Bozza, Marcelo T ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ANTIBODY; CELL COMPONENT; DISEASE; DISINFECTION; IMMUNITY; INFECTIOUS DISEASE; TOXICITY; VACCINE; VIRAL DISEASE; ZIKA VIRUS DISEASE;

ADOPTIVE TRANSFER; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIMARY INFECTION; RECIPIENT; SIGNAL TRANSDUCTION; VIRUS LOAD; ZIKA FEVER; ADAPTIVE IMMUNITY; ANIMAL; BODY WEIGHT; CHLOROCEBUS AETHIOPS; FEMALE; IMMUNOLOGY; MALE; METABOLISM; VERO CELL LINE; ZIKA VIRUS;

MURINAE; MUS; ZIKA VIRUS;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BODY WEIGHT; CD4-POSITIVE T-LYMPHOCYTES; CERCOPITHECUS AETHIOPS; FEMALE; IMMUNOGLOBULIN G; INTERFERON-GAMMA; MALE; MICE; VERO CELLS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85051265733     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/s41467-018-05519-4     Document Type: Article

References (63)

1. Dick, G. W., Kitchen, S. F. & Haddow, A. J. Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46, 509–520 (1952)
2. Carteaux, G. et al. Zika virus associated with meningoencephalitis. N. Engl. J. Med. 374, 1595–1596 (2016)
3. do Rosario, M. S. et al. Guillain–Barre syndrome after zika virus infection in Brazil. Am. J. Trop. Med. Hyg. 95, 1157–1160 (2016)
4. Dos Santos, T. et al. Zika virus and the Guillain–Barre syndrome—case series from seven countries. N. Engl. J. Med. 375, 1598–1601 (2016)
5. Mecharles, S. et al. Acute myelitis due to Zika virus infection. Lancet 387, 1481 (2016)
6. Parra, B. et al. Guillain–Barre syndrome associated with Zika virus infection in Colombia. N. Engl. J. Med. 375, 1513–1523 (2016)
7. Brasil, P. et al. Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med. 375, 2321–2334 (2016)
8. de Araujo, T. V. B. et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect. Dis. 16, 1356–1363 (2016)
9. Aragao, M. D. F. V. et al. Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study. Br. Med. J. 353, i1901 (2016)
10. Garcez, P. P. et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 352, 816–818 (2016)
11. Tang, H. et al. Zika virus infects human cortical neural progenitors and attenuates their growth. Cell Stem Cell 18, 587–590 (2016)
12. Aid, M. et al. Zika virus persistence in the central nervous system and lymph nodes of rhesus monkeys. Cell 169, 610–620 e614 (2017)
13. Barzon, L. et al. Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016. Euro Surveill. 21, 2–5 (2016)
14. Foy, B. D. et al. Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis. 17, 880–882 (2011)
15. Miner, J. J. & Diamond, M. S. Zika virus pathogenesis and tissue tropism. Cell Host Microbe 21, 134–142 (2017)
16. Yockey, L. J. et al. Vaginal exposure to Zika virus during pregnancy leads to fetal brain infection. Cell 166, 1247–1256 e1244 (2016)
17. Grant, A. et al. Zika virus targets human STAT2 to inhibit type-I interferon signaling. Cell Host Microbe 19, 882–890 (2016)
18. Kumar, A. et al. Zika virus inhibits type-I interferon production and downstream signaling. EMBO Rep. 17, 1766–1775 (2016)
19. Dowall, S. D. et al. Lineage-dependent differences in the disease progression of Zika virus infection in type-I interferon receptor knockout (A129) mice. PLoS Negl. Trop. Dis. 11, e0005704 (2017)
20. Lazear, H. M. et al. A mouse model of Zika virus pathogenesis. Cell Host Microbe 19, 720–730 (2016)
21. Manangeeswaran, M., Ireland, D. D. & Verthelyi, D. Zika (PRVABC59) infection is associated with T cell infiltration and neurodegeneration in CNS of immunocompetent neonatal C57Bl/6 mice. PLoS Pathog. 12, e1006004 (2016)
22. Tripathi, S. et al. A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses. PLoS Pathog. 13, e1006258 (2017)
23. Cugola, F. R. et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 534, 267–271 (2016)
24. Winkler, C. W. et al. Adaptive immune responses to Zika virus are important for controlling virus infection and preventing infection in brain and testes. J. Immunol. 198, 3526–3535 (2017)
25. Scott, J. M. et al. Cellular and humoral immunity protect against vaginal Zika virus infection in mice. J. Virol. 92, e00038-18 (2018)
26. Elong Ngono, A. et al. Mapping and role of the CD8(+) T cell response during primary Zika virus infection in mice. Cell Host Microbe 21, 35–46 (2017)
27. Dai, L. et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe 19, 696–704 (2016)
28. Larocca, R. A. et al. Vaccine protection against Zika virus from Brazil. Nature 536, 474–478 (2016)
29. Richner, J. M. et al. Vaccine mediated protection against Zika virus-induced congenital disease. Cell 170, 273–283 e212 (2017)
30. Robbiani, D. F. et al. Recurrent potent human neutralizing antibodies to Zika virus in Brazil and Mexico. Cell 169, 597–609 e511 (2017)
31. Stettler, K. et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 353, 823–826 (2016)
32. Aliota, M. T. et al. Heterologous protection against Asian Zika virus challenge in rhesus macaques. PLoS Negl. Trop. Dis. 10, e0005168 (2016)
33. Barba-Spaeth, G. et al. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 536, 48–53 (2016)
34. Bardina, S. V. et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175–180 (2017)
35. Priyamvada, L. et al. Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc. Natl Acad. Sci. USA 113, 7852–7857 (2016)
36. Swanstrom, J. A. et al. Dengue virus envelope dimer epitope monoclonal antibodies isolated from dengue patients are protective against Zika virus. mBio 7, pii: e01123–16 (2016)
37. Diamond, M. S., Shrestha, B., Marri, A., Mahan, D. & Engle, M. B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus. J. Virol. 77, 2578–2586 (2003)
38. Huang, H. et al. CD8(+) T cell immune response in immunocompetent mice during Zika virus infection. J. Virol. 91, pii: e00900–17 (2017)
39. Yauch, L. E. et al. CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J. Immunol. 185, 5405–5416 (2010)
40. Yauch, L. E. et al. A protective role for dengue virus-specific CD8+ T cells. J. Immunol. 182, 4865–4873 (2009)
41. Zellweger, R. M., Eddy, W. E., Tang, W. W., Miller, R. & Shresta, S. CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. J. Immunol. 193, 4117–4124 (2014)
42. Rivino, L. & Lim, M. Q. CD4(+) and CD8(+) T-cell immunity to Dengue—lessons for the study of Zika virus. Immunology 150, 146–154 (2017)
43. Shresta, S. et al. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B cell-dependent immunity are less critical. J. Virol. 78, 2701–2710 (2004)
44. Murali-Krishna, K., Ravi, V. & Manjunath, R. Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells. J. Gen. Virol. 77, 705–714 (1996)
45. Sitati, E. M. & Diamond, M. S. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 80, 12060–12069 (2006)
46. Brien, J. D., Uhrlaub, J. L. & Nikolich-Zugich, J. West Nile virus-specific CD4 T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection. J. Immunol. 181, 8568–8575 (2008)
47. Lanteri, M. C. et al. Tregs control the development of symptomatic West Nile virus infection in humans and mice. J. Clin. Invest. 119, 3266–3277 (2009)
48. Donald, C. L. et al. Full genome sequence and sfRNA interferon antagonist activity of Zika virus from Recife, Brazil. PLoS Negl. Trop. Dis. 10, e0005048 (2016)
49. Yuan, L. et al. A single mutation in the prM protein of Zika virus contributes to fetal microcephaly. Science 358, 933–936 (2017)
50. Shan, C. et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat. Med. 23, 763–767 (2017)
51. Jurado, K. A. et al. Antiviral CD8 T cells induce Zika virus-associated paralysis in mice. Nat. Microbiol. 3, 141–147 (2018)
52. Nazerai, L. et al. A new in vivo model to study protective immunity to Zika virus infection in mice with intact type-I interferon signaling. Front. Immunol. 9, 593 (2018)
53. Aliota, M. T. et al. Characterization of lethal Zika virus infection in AG129 Mice. PLoS Negl. Trop. Dis. 10, e0004682 (2016)
54. Rossi, S. L. et al. Characterization of a novel murine model to study Zika virus. Am. J. Trop. Med. Hyg. 94, 1362–1369 (2016)
55. Johnson, A. J. & Roehrig, J. T. New mouse model for dengue virus vaccine testing. J. Virol. 73, 783–786 (1999)
56. Prestwood, T. R. et al. Gamma interferon (IFN-gamma) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-alpha/beta receptor-deficient mice. J. Virol. 86, 12561–12570 (2012)
57. Sumathy, K. et al. Protective efficacy of Zika vaccine in AG129 mouse model. Sci. Rep. 7, 46375 (2017)
58. Iijima, N. & Iwasaki, A. Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help. Nature 533, 552–556 (2016)
59. Papa, M. P. et al. Zika virus infects, activates, and crosses brain microvascular endothelial cells, without barrier disruption. Front. Microbiol. 8, 2557 (2017)
60. Diamond, M. S. et al. A critical role for induced IgM in the protection against West Nile virus infection. J. Exp. Med. 198, 1853–1862 (2003)
61. Coelho, S. V. A. et al. Development of standard methods for Zika virus propagation, titration, and purification. J. Virol. Methods 246, 65–74 (2017)
62. Lanciotti, R. S. et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007 Emerg. Infect. Dis. 14, 1232–1239 (2008)
63. Lenth, R. V. Statistical power calculations. J. Anim. Sci. 85, E24–E29 (2007)